speb/financial-data huggingface dataset:
AVGO.TO income_statement (quarterly, 2025-01-31) — Net Income From Continuing Operation Net Minority Interest: 5503000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Income From Continuing Operations: 5503000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Net Income Including Noncontrolling Interests: 5503000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Net Interest Income: -873000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Investment Purchase And Sale: -87000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Issuance Payments Of Debt: -1124000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Long Term Debt Issuance: -5104000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Net Non Operating Interest Income Expense: -873000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Other Financing Charges: -46000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Other Investing Changes: 13000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Net PPE: 2465000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net PPE Purchase And Sale: -100000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Net Short Term Debt Issuance: 3980000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Net Tangible Assets: -66665000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Liabilities: 8645000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Revenue: 4628000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Non Current Deferred Taxes Liabilities: 4017000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Normalized EBITDA: 8709000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Normalized Income: 5638880000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Operating Cash Flow: 6113000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Operating Gains Losses: 65000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Operating Income: 6432000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Operating Revenue: 14916000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Ordinary Shares Number: 4702000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Current Assets: 813000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Current Borrowings: 1650000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Current Liabilities: 1124000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Equity Adjustments: 207000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Other Income Expense: -69000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Intangible Assets: 38583000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Other Non Cash Items: 138000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Non Current Assets: 5449000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Non Current Liabilities: 1467000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Other Non Operating Income Expenses: 103000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Other Receivables: 2722000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Payables: 2728000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Payables And Accrued Expenses: 3303000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Pensionand Other Post Retirement Benefit Plans Current: 922000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Prepaid Assets: 1285000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Pretax Income: 5490000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Purchase Of Business: 0.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Purchase Of Investment: -105000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Purchase Of PPE: -100000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Raw Materials: 393000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Receivables: 7677000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Reconciled Cost Of Revenue: 3108000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Reconciled Depreciation: 2174000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Repayment Of Debt: -8090000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Repurchase Of Capital Stock: -2036000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Research And Development: 2253000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Restructuring And Mergern Acquisition: 172000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Retained Earnings: 2729000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Sale Of Investment: 18000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Selling General And Administration: 949000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Share Issued: 4702000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Short Term Debt Issuance: 3980000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Special Income Charges: -172000000.00
AVGO.TO cash_flow (quarterly, 2025-01-31) — Stock Based Compensation: 1280000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Stockholders Equity: 69789000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Tangible Book Value: -66665000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Tax Effect Of Unusual Items: -36120000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Tax Provision: -13000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Tax Rate For Calcs: 0.21
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Assets: 165358000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Capitalization: 130704000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Debt: 66579000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Equity Gross Minority Interest: 69789000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Total Expenses: 8484000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Liabilities Net Minority Interest: 95569000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Assets: 144368000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Non Current Liabilities Net Minority Interest: 74659000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Total Operating Income As Reported: 6260000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Total Tax Payable: 823000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items: -172000000.00
AVGO.TO income_statement (quarterly, 2025-01-31) — Total Unusual Items Excluding Goodwill: -172000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Tradeand Other Payables Non Current: 3621000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Work In Process: 950000000.00
AVGO.TO balance_sheet (quarterly, 2025-01-31) — Working Capital: 80000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — +Operating Expense: 4282000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — +Total Revenue: 15004000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Accounts Payable: 1297000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Accounts Receivable: 5563000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Additional Paid In Capital: 66689000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Amortization: 506000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Amortization Cash Flow: 2024000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Amortization Of Intangibles: 2024000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Amortization Of Intangibles Income Statement: 506000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Basic Average Shares: 26662210692.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Basic EPS: 0.19
AVGO.TO cash_flow (quarterly, 2025-04-30) — Beginning Cash Position: 9307000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Capital Expenditure: -144000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Capital Lease Obligations: 11000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Cash And Cash Equivalents: 9472000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Cash Cash Equivalents And Short Term Investments: 9472000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Cash Dividends Paid: -2785000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Financing Activities: -6257000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Investing Activities: -133000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Cash Flow From Continuing Operating Activities: 6555000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Account Payable: -613000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Inventory: -109000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Other Working Capital: -598000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Payable: -613000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Payables And Accrued Expense: -613000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Receivables: -590000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Change In Working Capital: -1910000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Changes In Account Receivables: -590000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Changes In Cash: 165000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Commercial Paper: 3877000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Common Stock: 5000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Common Stock Dividend Paid: -2785000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Common Stock Equity: 69586000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Common Stock Payments: -4216000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Cost Of Revenue: 4807000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Accrued Expenses: 562000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Assets: 22181000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Capital Lease Obligation: 4000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Debt: 5527000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Debt And Capital Lease Obligation: 5531000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Liabilities: 10303000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Deferred Revenue: 10303000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Current Liabilities: 20597000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Deferred Income Tax: -571000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Deferred Tax: -571000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Depreciation: 142000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Depreciation Amortization Depletion: 2166000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Depreciation Amortization Depletion Income Statement: 506000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Depreciation And Amortization: 2166000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Depreciation And Amortization In Income Statement: 506000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Diluted Average Shares: 27336271256.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Diluted EPS: 0.18
AVGO.TO income_statement (quarterly, 2025-04-30) — Diluted NI Availto Com Stockholders: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — EBIT: 5854000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — EBITDA: 8020000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — End Cash Position: 9472000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Financing Cash Flow: -6257000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Finished Goods: 500000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Free Cash Flow: 6411000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Gains Losses Not Affecting Retained Earnings: 206000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Goodwill And Other Intangible Assets: 134194000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Gross Profit: 10197000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Income Tax Paid Supplemental Data: 608000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Interest Expense: 769000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Interest Expense Non Operating: 769000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Interest Paid Supplemental Data: 700000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Interest Payable: 562000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Inventory: 2017000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Invested Capital: 136857000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Investing Cash Flow: -133000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Issuance Of Debt: 630000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Long Term Capital Lease Obligation: 7000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Long Term Debt: 61744000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Long Term Debt And Capital Lease Obligation: 61751000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Long Term Debt Issuance: 749000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Long Term Debt Payments: 0.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Business Purchase And Sale: 0.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Common Stock Issuance: -4098000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Net Debt: 57799000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income Common Stockholders: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income Continuous Operations: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income Discontinuous Operations: 0.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing And Discontinued Operation: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income From Continuing Operation Net Minority Interest: 4965000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Income From Continuing Operations: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Income Including Noncontrolling Interests: 4965000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Interest Income: -769000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Investment Purchase And Sale: 21000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Issuance Payments Of Debt: 630000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Long Term Debt Issuance: 749000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Net Non Operating Interest Income Expense: -769000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Other Financing Charges: -4000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Other Investing Changes: -10000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Net PPE: 2462000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net PPE Purchase And Sale: -144000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Net Short Term Debt Issuance: -119000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Net Tangible Assets: -64608000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Liabilities: 7519000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Revenue: 4154000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Non Current Deferred Taxes Liabilities: 3365000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Normalized EBITDA: 8106000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Normalized Income: 5048970501.47
AVGO.TO cash_flow (quarterly, 2025-04-30) — Operating Cash Flow: 6555000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Operating Gains Losses: 0.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Operating Income: 5915000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Operating Revenue: 15004000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Ordinary Shares Number: 4703000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Current Assets: 959000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Current Borrowings: 1650000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Current Liabilities: 992000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Equity Adjustments: 206000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Other Income Expense: -61000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Intangible Assets: 36393000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Other Non Cash Items: 134000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Non Current Assets: 5793000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Non Current Liabilities: 1445000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Other Non Operating Income Expenses: 25000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Other Receivables: 3234000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Payables: 1943000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Payables And Accrued Expenses: 2505000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Pensionand Other Post Retirement Benefit Plans Current: 1266000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Prepaid Assets: 936000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Pretax Income: 5085000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Purchase Of Business: 0.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Purchase Of Investment: -57000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Purchase Of PPE: -144000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Raw Materials: 398000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Receivables: 8797000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Reconciled Cost Of Revenue: 3147000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Reconciled Depreciation: 2166000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Repayment Of Debt: 0.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Repurchase Of Capital Stock: -4216000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Research And Development: 2693000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Restructuring And Mergern Acquisition: 86000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Retained Earnings: 2686000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Sale Of Investment: 78000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Selling General And Administration: 1083000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Share Issued: 4703000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Short Term Debt Issuance: -119000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Special Income Charges: -86000000.00
AVGO.TO cash_flow (quarterly, 2025-04-30) — Stock Based Compensation: 1771000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Stockholders Equity: 69586000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Tangible Book Value: -64608000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Tax Effect Of Unusual Items: -2029498.53
AVGO.TO income_statement (quarterly, 2025-04-30) — Tax Provision: 120000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Tax Rate For Calcs: 0.02
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Assets: 164630000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Capitalization: 131330000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Debt: 67282000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Equity Gross Minority Interest: 69586000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Total Expenses: 9089000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Liabilities Net Minority Interest: 95044000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Assets: 142449000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Non Current Liabilities Net Minority Interest: 74447000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Total Operating Income As Reported: 5829000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Total Tax Payable: 646000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items: -86000000.00
AVGO.TO income_statement (quarterly, 2025-04-30) — Total Unusual Items Excluding Goodwill: -86000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Tradeand Other Payables Non Current: 3732000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Work In Process: 1119000000.00
AVGO.TO balance_sheet (quarterly, 2025-04-30) — Working Capital: 1584000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — +Operating Expense: 4629000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — +Total Revenue: 15952000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Accounts Payable: 1432000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Accounts Receivable: 6494000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 69011000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Amortization: 507000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Amortization Cash Flow: 2060000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Amortization Of Intangibles: 2060000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Amortization Of Intangibles Income Statement: 507000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Basic Average Shares: 26701861313.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Basic EPS: 0.16
AVGO.TO cash_flow (quarterly, 2025-07-31) — Beginning Cash Position: 9472000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Capital Expenditure: -142000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Capital Lease Obligations: 10000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 10718000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 10718000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Cash Dividends Paid: -2786000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Financing Activities: -6014000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Investing Activities: 94000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Cash Flow From Continuing Operating Activities: 7166000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Account Payable: 136000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Inventory: -163000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Other Working Capital: -930000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Payable: 136000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Payables And Accrued Expense: 136000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Receivables: -937000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Change In Working Capital: -1894000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Changes In Account Receivables: -937000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Changes In Cash: 1246000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Commercial Paper: 496000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Common Stock: 5000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Common Stock Dividend Paid: -2786000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 73277000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Common Stock Issuance: 0.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Common Stock Payments: -58000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Cost Of Revenue: 5249000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 644000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Assets: 24998000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Capital Lease Obligation: 3000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Debt: 1396000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Debt And Capital Lease Obligation: 1399000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Liabilities: 10305000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Deferred Revenue: 10305000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 16704000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Deferred Income Tax: 284000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Deferred Tax: 284000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Depreciation: 142000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Depreciation Amortization Depletion: 2202000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Depreciation Amortization Depletion Income Statement: 507000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Depreciation And Amortization: 2202000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Depreciation And Amortization In Income Statement: 507000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Diluted Average Shares: 27528859988.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Diluted EPS: 0.15
AVGO.TO income_statement (quarterly, 2025-07-31) — Diluted NI Availto Com Stockholders: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — EBIT: 6092000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — EBITDA: 8294000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — End Cash Position: 10718000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Financing Cash Flow: -6014000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Finished Goods: 477000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Free Cash Flow: 7024000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Gains Losses Not Affecting Retained Earnings: 221000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Goodwill And Other Intangible Assets: 132145000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Gross Profit: 10703000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Income Tax Paid Supplemental Data: 822000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Interest Expense: 807000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Interest Expense Non Operating: 807000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Interest Paid Supplemental Data: 602000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Interest Payable: 644000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Inventory: 2180000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Invested Capital: 137496000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Investing Cash Flow: 94000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Issuance Of Capital Stock: 0.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Issuance Of Debt: 3587000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Long Term Capital Lease Obligation: 7000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt: 62823000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Long Term Debt And Capital Lease Obligation: 62830000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Long Term Debt Issuance: 6960000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Long Term Debt Payments: -6750000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Business Purchase And Sale: 300000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Common Stock Issuance: -58000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Net Debt: 53501000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income Common Stockholders: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income Continuous Operations: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income Discontinuous Operations: 0.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing And Discontinued Operation: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income From Continuing Operation Net Minority Interest: 4140000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Income From Continuing Operations: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Income Including Noncontrolling Interests: 4140000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Interest Income: -807000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Investment Purchase And Sale: -48000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Issuance Payments Of Debt: -3163000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Long Term Debt Issuance: 210000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Net Non Operating Interest Income Expense: -807000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Other Financing Charges: -7000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Other Investing Changes: -16000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Net PPE: 2451000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net PPE Purchase And Sale: -142000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Net Short Term Debt Issuance: -3373000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: -58868000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Liabilities: 7583000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Revenue: 4031000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Taxes Liabilities: 3552000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Normalized EBITDA: 8481000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Normalized Income: 4286486281.93
AVGO.TO cash_flow (quarterly, 2025-07-31) — Operating Cash Flow: 7166000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Operating Gains Losses: 53000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Operating Income: 6074000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Operating Revenue: 15952000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 4722000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Current Assets: 656000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Current Borrowings: 900000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Current Liabilities: 795000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Equity Adjustments: 221000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Other Income Expense: 18000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Intangible Assets: 34344000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Other Non Cash Items: 59000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Non Current Assets: 6027000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Non Current Liabilities: 1410000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Other Non Operating Income Expenses: 205000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Other Receivables: 4157000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Payables: 1842000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 2486000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Pensionand Other Post Retirement Benefit Plans Current: 1719000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Prepaid Assets: 793000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Pretax Income: 5285000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Business: 0.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of Investment: -99000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Purchase Of PPE: -142000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Raw Materials: 354000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Receivables: 10651000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Reconciled Cost Of Revenue: 3554000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Reconciled Depreciation: 2202000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Repayment Of Debt: -6750000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Repurchase Of Capital Stock: -58000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Research And Development: 3050000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Restructuring And Mergern Acquisition: 187000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Retained Earnings: 4040000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Sale Of Investment: 51000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Selling General And Administration: 1072000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Share Issued: 4722000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Short Term Debt Issuance: -3373000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Special Income Charges: -187000000.00
AVGO.TO cash_flow (quarterly, 2025-07-31) — Stock Based Compensation: 2322000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 73277000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: -58868000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Tax Effect Of Unusual Items: -40513718.07
AVGO.TO income_statement (quarterly, 2025-07-31) — Tax Provision: 1145000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Tax Rate For Calcs: 0.22
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Assets: 165621000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 136100000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Debt: 64229000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 73277000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Total Expenses: 9878000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 92344000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 140623000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 75640000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Total Operating Income As Reported: 5887000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Total Tax Payable: 410000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items: -187000000.00
AVGO.TO income_statement (quarterly, 2025-07-31) — Total Unusual Items Excluding Goodwill: -187000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Tradeand Other Payables Non Current: 3817000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Work In Process: 1349000000.00
AVGO.TO balance_sheet (quarterly, 2025-07-31) — Working Capital: 8294000000.00
AVGO.TO income_statement (annual, 2025-10-31) — +Operating Expense: 17219000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — +Operating Expense: 4595000000.00
AVGO.TO income_statement (annual, 2025-10-31) — +Total Revenue: 63887000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — +Total Revenue: 18015000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Accounts Payable: 1560000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Accounts Payable: 1560000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Accounts Receivable: 7145000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Accounts Receivable: 7145000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Accumulated Depreciation: -4896000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Accumulated Depreciation: -4896000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Additional Paid In Capital: 71308000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Additional Paid In Capital: 71308000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -74000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Allowance For Doubtful Accounts Receivable: -74000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Amortization: 2031000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Amortization: 507000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Amortization Cash Flow: 8201000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Amortization Cash Flow: 2085000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Amortization Of Intangibles: 8201000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Amortization Of Intangibles: 2085000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Amortization Of Intangibles Income Statement: 2031000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Amortization Of Intangibles Income Statement: 507000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Basic Average Shares: 26690532564.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Basic Average Shares: 26803820054.00
AVGO.TO income_statement (annual, 2025-10-31) — Basic EPS: 0.87
AVGO.TO income_statement (quarterly, 2025-10-31) — Basic EPS: 0.32
AVGO.TO cash_flow (annual, 2025-10-31) — Beginning Cash Position: 9348000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Beginning Cash Position: 10718000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Buildings And Improvements: 1488000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Buildings And Improvements: 1488000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Capital Expenditure: -623000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Capital Expenditure: -237000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Capital Lease Obligations: 0.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Capital Lease Obligations: 0.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Capital Stock: 5000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Cash And Cash Equivalents: 16178000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Cash And Cash Equivalents: 16178000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 16178000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Cash Cash Equivalents And Short Term Investments: 16178000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Cash Dividends Paid: -11142000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Cash Dividends Paid: -2797000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Financing Activities: -20127000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Financing Activities: -1876000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Investing Activities: -580000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Investing Activities: -367000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Cash Flow From Continuing Operating Activities: 27537000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Cash Flow From Continuing Operating Activities: 7703000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Account Payable: -118000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Account Payable: 118000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Inventory: -510000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Inventory: -90000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Other Working Capital: -5155000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Other Working Capital: -1722000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Payable: -118000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Payable: 118000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Payables And Accrued Expense: -118000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Payables And Accrued Expense: 118000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Receivables: -2717000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Receivables: -651000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Change In Working Capital: -8500000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Change In Working Capital: -2345000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Changes In Account Receivables: -2717000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Changes In Account Receivables: -651000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Changes In Cash: 6830000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Changes In Cash: 5460000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Common Stock: 5000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Common Stock: 5000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Common Stock Dividend Paid: -11142000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Common Stock Dividend Paid: -2797000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Common Stock Equity: 81292000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Common Stock Equity: 81292000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Common Stock Issuance: 221000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Common Stock Issuance: 103000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Common Stock Payments: -6310000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Common Stock Payments: 0.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Construction In Progress: 78000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Construction In Progress: 78000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Cost Of Revenue: 20593000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Cost Of Revenue: 5766000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Accrued Expenses: 620000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Accrued Expenses: 620000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Assets: 31573000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Assets: 31573000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Capital Lease Obligation: 0.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Capital Lease Obligation: 0.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Debt: 3152000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Debt: 3152000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Debt And Capital Lease Obligation: 3152000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Debt And Capital Lease Obligation: 3152000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Deferred Liabilities: 9469000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Liabilities: 9469000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Deferred Revenue: 9469000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Deferred Revenue: 9469000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Current Liabilities: 18514000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Current Liabilities: 18514000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Deferred Income Tax: -4008000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Deferred Income Tax: -3025000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Deferred Tax: -4008000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Deferred Tax: -3025000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Depreciation: 574000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Depreciation: 148000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Depreciation Amortization Depletion: 8775000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Depreciation Amortization Depletion: 2233000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 2031000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Depreciation Amortization Depletion Income Statement: 507000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Depreciation And Amortization: 8775000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Depreciation And Amortization: 2233000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Depreciation And Amortization In Income Statement: 2031000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Depreciation And Amortization In Income Statement: 507000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Diluted Average Shares: 27489209367.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Diluted Average Shares: 27693126848.00
AVGO.TO income_statement (annual, 2025-10-31) — Diluted EPS: 0.84
AVGO.TO income_statement (quarterly, 2025-10-31) — Diluted EPS: 0.31
AVGO.TO income_statement (annual, 2025-10-31) — Diluted NI Availto Com Stockholders: 23126000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Diluted NI Availto Com Stockholders: 8518000000.00
AVGO.TO income_statement (annual, 2025-10-31) — EBIT: 25939000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — EBIT: 7630000000.00
AVGO.TO income_statement (annual, 2025-10-31) — EBITDA: 34714000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — EBITDA: 9863000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — End Cash Position: 16178000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — End Cash Position: 16178000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Financing Cash Flow: -20127000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Financing Cash Flow: -1876000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Finished Goods: 682000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Finished Goods: 682000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Free Cash Flow: 26914000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Free Cash Flow: 7466000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Gain On Sale Of Security: -17000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 218000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Gains Losses Not Affecting Retained Earnings: 218000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Goodwill: 97801000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Goodwill And Other Intangible Assets: 130074000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Goodwill And Other Intangible Assets: 130074000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Gross Accounts Receivable: 7219000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Gross Accounts Receivable: 7219000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Gross PPE: 7426000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Gross PPE: 7426000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Gross Profit: 43294000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Gross Profit: 12249000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Income Tax Paid Supplemental Data: 2589000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Income Tax Paid Supplemental Data: 755000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Interest Expense: 3210000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Interest Expense: 761000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Interest Expense Non Operating: 3210000000.00
AVGO.TO income_statement (quarterly, 2025-10-31) — Interest Expense Non Operating: 761000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Interest Income: 347000000.00
AVGO.TO income_statement (annual, 2025-10-31) — Interest Income Non Operating: 347000000.00
AVGO.TO cash_flow (annual, 2025-10-31) — Interest Paid Supplemental Data: 2672000000.00
AVGO.TO cash_flow (quarterly, 2025-10-31) — Interest Paid Supplemental Data: 699000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Interest Payable: 620000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Interest Payable: 620000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Inventory: 2270000000.00
AVGO.TO balance_sheet (quarterly, 2025-10-31) — Inventory: 2270000000.00
AVGO.TO balance_sheet (annual, 2025-10-31) — Invested Capital: 146428000000.00